M.J. Barbanoj

1.7k total citations
45 papers, 1.3k citations indexed

About

M.J. Barbanoj is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M.J. Barbanoj has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cognitive Neuroscience, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M.J. Barbanoj's work include EEG and Brain-Computer Interfaces (12 papers), Sleep and Wakefulness Research (9 papers) and Neural dynamics and brain function (6 papers). M.J. Barbanoj is often cited by papers focused on EEG and Brain-Computer Interfaces (12 papers), Sleep and Wakefulness Research (9 papers) and Neural dynamics and brain function (6 papers). M.J. Barbanoj collaborates with scholars based in Spain, Austria and United States. M.J. Barbanoj's co-authors include Jaime Kulisevsky, Víctor Pérez, B. Saletu, Sergio Romero, Elinor Thompson, Thomas E. Schläepfer, José Luis Rodríguez Martín, P. Anderer, Miguel Ángel Mañanas and Georg Dorffner and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

M.J. Barbanoj

43 papers receiving 1.2k citations

Peers

M.J. Barbanoj
Waldemar Szelenberger Poland
Bartolo Lanuzza Italy
Govinda Poudel Australia
Stephen F. Lewis United States
Ricardo Bajo Spain
Klaus Mann Germany
Karina Rabello Casali Brazil
Jean‐François Giguère Canada
Hovagim Bakardjian France
Waldemar Szelenberger Poland
M.J. Barbanoj
Citations per year, relative to M.J. Barbanoj M.J. Barbanoj (= 1×) peers Waldemar Szelenberger

Countries citing papers authored by M.J. Barbanoj

Since Specialization
Citations

This map shows the geographic impact of M.J. Barbanoj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Barbanoj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Barbanoj more than expected).

Fields of papers citing papers by M.J. Barbanoj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Barbanoj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Barbanoj. The network helps show where M.J. Barbanoj may publish in the future.

Co-authorship network of co-authors of M.J. Barbanoj

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Barbanoj. A scholar is included among the top collaborators of M.J. Barbanoj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Barbanoj. M.J. Barbanoj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbanoj, M.J., María Rosa Ballester, Rosa María Antonijoan, et al.. (2009). Comparison of repeated‐dose pharmacokinetics of prolonged‐release and immediate‐release torasemide formulations in healthy young volunteers. Fundamental and Clinical Pharmacology. 23(1). 115–125. 6 indexed citations
2.
Antonijoan, Rosa María, Salvador Rico, Javier Martínez, et al.. (2009). Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 47(12). 726–732. 5 indexed citations
3.
Izquierdo, Iñaki, Iñaki Pérez, Olga García, et al.. (2009). No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a ‘thorough QT/QTc study’ performed according to ICH guidelines. British Journal of Clinical Pharmacology. 69(4). 401–410. 29 indexed citations
4.
Pérez, Víctor, et al.. (2009). Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances. Journal of Neural Transmission. 116(10). 1257–1266. 25 indexed citations
5.
Romero, Sergio, Miguel Ángel Mañanas, & M.J. Barbanoj. (2008). Ocular Reduction in EEG Signals Based on Adaptive Filtering, Regression and Blind Source Separation. Annals of Biomedical Engineering. 37(1). 176–191. 52 indexed citations
6.
7.
Poza, Jesús, P. Caminal, Montserrat Vallverdú, et al.. (2007). Study of the EEG Changes during the Combined Ingestion of Alcohol and H<inf>1</inf>-antihistamines by using the Wavelet Transform. Conference proceedings. 153. 23–26. 2 indexed citations
8.
Barbanoj, M.J., Gloria Urbano, Rosa María Antonijoan, María Rosa Ballester, & Marta Valle. (2007). Different Acute Tolerance Development to EEG, Psychomotor Performance and Subjective Assessment Effects after Two Intermittent Oral Doses of Alprazolam in Healthy Volunteers. Neuropsychobiology. 55(3-4). 203–212. 12 indexed citations
9.
Barbanoj, M.J., et al.. (2006). Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. Human Psychopharmacology Clinical and Experimental. 21(1). 13–26. 41 indexed citations
10.
Barbanoj, M.J., Rosa María Antonijoan, Jordi Riba, et al.. (2006). Quantifying Drug-Drug Interactions in Pharmaco-EEG. Clinical EEG and Neuroscience. 37(2). 108–120. 9 indexed citations
11.
Tomlinson, Brian, G. Neil Thomas, M.J. Barbanoj, et al.. (2006). Pharmacokinetic Profile of the Somatostatin Analogue Lanreotide in Individuals with Chronic Hepatic Insufficiency. Clinical Pharmacokinetics. 45(10). 1003–1011. 7 indexed citations
12.
Romero, Sergio, Miguel Ángel Mañanas, Jordi Riba, et al.. (2005). Evaluation of an automatic ocular filtering method for awake spontaneous EEG signals based on independent component analysis. PubMed. 3. 925–928. 12 indexed citations
13.
Barbanoj, M.J., S. Clos, Sergio Romero, et al.. (2005). Sleep Laboratory Study on Single and Repeated Dose Effects of Paroxetine, Alprazolam and Their Combination in Healthy Young Volunteers. Neuropsychobiology. 51(3). 134–147. 17 indexed citations
14.
Martín, José Luis Rodríguez, M.J. Barbanoj, Thomas E. Schläepfer, et al.. (2003). Repetitive transcranial magnetic stimulation for the treatment of depression. The British Journal of Psychiatry. 182(6). 480–491. 230 indexed citations
15.
Rodrı́guez-Fornells, Antoni, Jordi Riba, Alexandre Gironell, Jaime Kulisevsky, & M.J. Barbanoj. (1999). Effects of alprazolam on the acoustic startle response in humans. Psychopharmacology. 143(3). 280–285. 37 indexed citations
16.
Barbanoj, M.J., et al.. (1997). NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL. Pharmacological Research. 36(1). 41–47. 6 indexed citations
17.
Anderer, P., M.J. Barbanoj, B. Saletu, & Heribert V. Semlitsch. (1993). Restriction to a Limited Set of EEG-Target Variables May Lead to Misinterpretation of Pharmaco-EEG Results. Neuropsychobiology. 27(2). 112–116. 16 indexed citations
18.
Barbanoj, M.J., et al.. (1990). Evaluation of Psychotropic Drug Consumption Related to Psychological Distress in the Elderly: Hospitalized vs. Nonhospitalized. Neuropsychobiology. 23(1). 25–30. 7 indexed citations
19.
Ramis, Joaquim, et al.. (1990). Pharmacokinetics of triflusal after single and repeated doses in man.. PubMed. 28(8). 344–9. 24 indexed citations
20.
Torrent, Josep Maria Ustrell i, Iñaki Izquierdo, M.J. Barbanoj, et al.. (1988). Theophylline pharmacokinetics following single and repeated administration of slow-release capsules. European Journal of Drug Metabolism and Pharmacokinetics. 13(4). 225–230. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waldemar Szelenberger Breakdown of academic impact, for papers by Bartolo Lanuzza Breakdown of academic impact, for papers by Govinda Poudel Breakdown of academic impact, for papers by Stephen F. Lewis Breakdown of academic impact, for papers by Ricardo Bajo Breakdown of academic impact, for papers by Klaus Mann Breakdown of academic impact, for papers by Karina Rabello Casali Breakdown of academic impact, for papers by Jean‐François Giguère Breakdown of academic impact, for papers by Hovagim Bakardjian
Rankless by CCL
2026